Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Seer Inc Cl A (SEER)

Seer Inc Cl A (SEER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 106,228
  • Shares Outstanding, K 64,773
  • Annual Sales, $ 16,660 K
  • Annual Income, $ -86,280 K
  • 60-Month Beta 1.45
  • Price/Sales 6.53
  • Price/Cash Flow N/A
  • Price/Book 0.28
Trade SEER with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 37.42%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.36
  • Number of Estimates 2
  • High Estimate -0.35
  • Low Estimate -0.36
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +2.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6200 +1.54%
on 07/02/24
1.9100 -13.87%
on 06/12/24
-0.1450 (-8.10%)
since 06/03/24
3-Month
1.6100 +2.17%
on 04/22/24
2.3000 -28.48%
on 05/08/24
-0.1750 (-9.62%)
since 04/03/24
52-Week
1.4550 +13.06%
on 11/16/23
5.6500 -70.88%
on 07/21/23
-2.4350 (-59.68%)
since 07/03/23

Most Recent Stories

More News
Why Shares of Seer Are Slumping Wednesday

The company reported a net loss but improved revenue in the second quarter.

SEER : 1.6500 (+0.61%)
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

/CNW/ -- Discovery Life Sciencesâ„¢ (Discovery) today announced the launch of its new Proteomic Services Division and is now accepting samples from...

SEER : 1.6500 (+0.61%)
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

/PRNewswire/ -- Discovery Life Sciencesâ„¢ (Discovery) today announced the launch of its new Proteomic Services Division and is now accepting samples from...

SEER : 1.6500 (+0.61%)
OLK : 25.74 (+0.04%)
Probius Emerges to Transform Data Acquisition for AI in Healthcare, adding John Baldoni, Chief Scientific Officer, and Juan C. Cuevas, SVP Marketing and Business Development

Probius, a deep tech company bridging the data gap between biology and AI, today announced the expansion of their leadership team. John Baldoni, PhD, has joined as Chief Scientific Officer, and Juan C....

SEER : 1.6500 (+0.61%)
TMO : 533.73 (-0.04%)
Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript

SEER earnings call for the period ending June 30, 2022.

SEER : 1.6500 (+0.61%)
Seer Reports Second Quarter 2022 Financial Results

Company launches novel proteogenomics workflow with the Proteographâ„¢ Analysis Suite 2.0, further demonstrates the power of its technology with new customer...

SEER : 1.6500 (+0.61%)
Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0

Scalable, high-resolution, sample-specific analysis brings genomics and proteomics together to enable novel biological insights with the click of a button...

SEER : 1.6500 (+0.61%)
Seer to Report Second Quarter 2022 Financial Results on August 9, 2022

REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for...

SEER : 1.6500 (+0.61%)
Seer, Inc. (SEER) Q1 2022 Earnings Call Transcript

SEER earnings call for the period ending March 31, 2022.

SEER : 1.6500 (+0.61%)
Seer Becomes Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

SEER : 1.6500 (+0.61%)

Business Summary

Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.

See More

Key Turning Points

3rd Resistance Point 1.7632
2nd Resistance Point 1.7305
1st Resistance Point 1.6853
Last Price 1.6500
1st Support Level 1.6074
2nd Support Level 1.5747
3rd Support Level 1.5295

See More

52-Week High 5.6500
Fibonacci 61.8% 4.0475
Fibonacci 50% 3.5525
Fibonacci 38.2% 3.0575
Last Price 1.6500
52-Week Low 1.4550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar